Global Anticoccidial Drugs Market Growth, Size, Share, Industry Report and Forecast 2020-2026

The anticoccidial drugs market is expected to show a modest growth rate at a CAGR of around 4% during the forecast period 2020-2026. Coccidiosis is one of the most common diseases in the chicken. It is an intestinal disease that is caused due to the parasitic organism attaching itself to a chicken’s intestinal lining due to which chicken is not able to absorb the required nutrients through intestines. Besides, it is also a prevalent disease in other animals including, cattle, swine, and companion animals. The disease is treatable most of the time through anticoccidial drugs if diagnosed at an early stage. Route of administration of the drug is through the water supply of chicken and if not possible, it is fed orally.

To Request a Free Sample of our Global Anticoccidial Drugs Market: https://www.omrglobal.com/request-sample/anticoccidial-drugs-market

High meat consumption, increasing awareness related to healthy food, rising disposable income, rising chances of zoonotic diseases (disease passing from animals & insect to people) are the key factors for the growth of the anticoccidial drugs industry across the globe. Factory farming for meat is on the rise globally where a large number of animals including cows, pigs, turkeys, goats, sheep, pigs, or chickens are kept together to increase productivity at the lowest possible cost. For instance, in the US, more than 95% of animals are produced in factory farming for maximizing agribusiness profit. These considerably raises the chances of spreading diseases among other fellow animals if one animal gets infected by a particular disease.

(Get 15% Discount on Buying this Report)

A full Report of Global Anticoccidial Drugs Market is Available at: https://www.omrglobal.com/industry-reports/anticoccidial-drugs-market

Moreover, government support to poultry and dairy farming and the development of a better supply chain of drugs are also considerable factors contributing to the growth of the market. However, an alternative solution such as vaccines for coccidiosis is also available in the European region which is a restraining factor for the drug market growth. In some regions, herbal medicines are also widely used for the treatment of coccidiosis which is restraining the market growth.

Global Anticoccidial Drugs Market Segmentation

By Drug Type

· Antibiotic

· Ionophore

· Chemical Derivative

By Animal Type

· Poultry

· Swine

· Cattle

· Companion Animal

· Other

Regional Analysis

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of The World

Company Profiles

· Bayer AG

· Bioproperties Pty. Ltd.

· BOEHRINGER Ingelheim International GmbH

· Ceva Santé Animale

· Elanco Animal Health Inc.

· Huvepharma EOOD

· Impextraco N.V.

· Kemin Industries, Inc.

· Merck & Co., Inc.

· Phibro Animal Health Corp.

· Qilu Animal Health Products Co., Ltd.

· Schering-Plough Corp.

· Venkateshwara Hatcheries Pvt. Ltd.

· Vetoquinol S.A.

· Virbac S.A.

· Zoetis, Inc.

Reasons to Buy From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anticoccidial-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.